City

Bethesda (1)

Groningen (1)

Houston (1)

New York (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Not yet recruiting (1)

Recruiting (1)

Terminated (1)

Phase

phase 2 (1)

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC (1)

M.D. Anderson Cancer Center (1)

National Institute of Neurological Disorders and Stroke (NINDS) (1)

University Medical Center Groningen (1)

Weill Medical College of Cornell University (1)

Collaborator

Novartis Pharmaceuticals (1)

Pfizer (1)

VHL Alliance (1)

Intervention

89zr bevacizumab pet scan (1)

ga68-dotatate-pet/mri (1)

observational (1)

su011248 (1)

Study Documents

Intervention Type

other (2)

diagnostic test (1)

drug (1)

Funder Type

Other (4)

NIH (1)

Study Type

Observational (3)

Interventional (1)

Observational [Patient Registry] (1)

hemangioblastoma

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Brain and Spinal Cord Tumor Growth and Cyst Development in Von

Active, not recruiting

Hemangioblastoma
Hippel Lindau Disease

Bethesda, Maryland

National Institutes of Health Clinical Center

Jan 25, 2023

68-Ga DOTATATE PET/MRI in Diagnosis and Management of

Recruiting

CNS Tumors
+6 more

Ga68-DOTATATE-PET/MRI

New York, New York

Weill Cornell Medicine

Sep 20, 2022

Glioma, Glioneuronal Tumor, Choroid Plexus Tumor Trial (Observational)

Not yet recruiting

Glioma
+12 more

Observational

(no location specified)

Feb 17, 2022

Visualizing Vascular Endothelial Growth Factor Producing Lesions

Completed

Von Hippel-Lindau Disease
+4 more

89Zr bevacizumab PET scan

Groningen, Netherlands

University Medical Center Groningen

Nov 5, 2012

Von Hippel-Lindau Syndrome, Renal Cell Carcinoma, Hemangioblastoma Trial in Houston (SU011248)

Terminated

Has Results

Von Hippel-Lindau Syndrome
+2 more

SU011248

Houston, Texas

UT MD Anderson Cancer Center

Feb 23, 2012